Guided Therapeutics, Inc. (GTHP)
USD 0.08
(-0.12%)
USD 0.08
(-0.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 36 Thousand USD | 27.94% |
| 2022 | -68 Thousand USD | -440.0% |
| 2021 | 20 Thousand USD | -67.21% |
| 2020 | 61 Thousand USD | 279.41% |
| 2019 | -34 Thousand USD | -6.25% |
| 2018 | -32 Thousand USD | 88.81% |
| 2017 | -286 Thousand USD | -355.36% |
| 2016 | 112 Thousand USD | 62.32% |
| 2015 | 69 Thousand USD | 201.47% |
| 2014 | -68 Thousand USD | -111.97% |
| 2013 | 568 Thousand USD | -82.75% |
| 2012 | 3.29 Million USD | -6.34% |
| 2011 | 3.51 Million USD | 4.52% |
| 2010 | 3.36 Million USD | 117.03% |
| 2009 | 1.55 Million USD | 17.69% |
| 2008 | 1.31 Million USD | 33.71% |
| 2007 | 985 Thousand USD | 2997.06% |
| 2006 | -34 Thousand USD | 92.33% |
| 2005 | -443 Thousand USD | -1130.56% |
| 2004 | -36 Thousand USD | -106.87% |
| 2003 | 524 Thousand USD | -75.9% |
| 2002 | 2.17 Million USD | 451.78% |
| 2001 | 394 Thousand USD | -89.33% |
| 2000 | 3.69 Million USD | 84.7% |
| 1999 | 2 Million USD | 900.0% |
| 1998 | 200 Thousand USD | -84.62% |
| 1997 | 1.3 Million USD | 62.5% |
| 1996 | 800 Thousand USD | -32.2% |
| 1995 | 1.18 Million USD | 883.33% |
| 1994 | 120 Thousand USD | 0.0% |
| 1993 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -24 Thousand USD | -26.32% |
| 2024 Q1 | -19 Thousand USD | -213.89% |
| 2023 Q3 | -4000.00 USD | -136.36% |
| 2023 FY | -49 Thousand USD | 27.94% |
| 2023 Q1 | 13 Thousand USD | 118.84% |
| 2023 Q4 | -6053.00 USD | -51.33% |
| 2023 Q2 | 11 Thousand USD | -15.38% |
| 2022 FY | -68 Thousand USD | -440.0% |
| 2022 Q3 | 3000.00 USD | -25.0% |
| 2022 Q2 | 4000.00 USD | 0.0% |
| 2022 Q1 | 4000.00 USD | -90.24% |
| 2022 Q4 | -69 Thousand USD | -2400.0% |
| 2021 Q3 | -23 Thousand USD | -1250.0% |
| 2021 Q1 | - USD | 100.0% |
| 2021 Q2 | 2000.00 USD | 0.0% |
| 2021 Q4 | 41 Thousand USD | 278.26% |
| 2021 FY | 20 Thousand USD | -67.21% |
| 2020 Q1 | - USD | -100.0% |
| 2020 Q4 | -35 Thousand USD | -153.85% |
| 2020 Q2 | -6000.00 USD | 0.0% |
| 2020 Q3 | 65 Thousand USD | 1183.33% |
| 2020 FY | 61 Thousand USD | 279.41% |
| 2019 Q1 | 17 Thousand USD | 138.64% |
| 2019 Q3 | 1000.00 USD | 101.56% |
| 2019 Q4 | 12 Thousand USD | 1100.0% |
| 2019 Q2 | -64 Thousand USD | -476.47% |
| 2019 FY | -34 Thousand USD | -6.25% |
| 2018 Q1 | 1000.00 USD | 100.44% |
| 2018 Q4 | -44 Thousand USD | -2300.0% |
| 2018 FY | -32 Thousand USD | 88.81% |
| 2018 Q2 | 7000.00 USD | 600.0% |
| 2018 Q3 | 2000.00 USD | -71.43% |
| 2017 Q4 | -228 Thousand USD | -256.25% |
| 2017 FY | -286 Thousand USD | -355.36% |
| 2017 Q1 | 5000.00 USD | 102.65% |
| 2017 Q2 | 5000.00 USD | 0.0% |
| 2017 Q3 | -64 Thousand USD | -1380.0% |
| 2016 FY | 112 Thousand USD | 62.32% |
| 2016 Q1 | 194 Thousand USD | 115.9% |
| 2016 Q3 | 10 Thousand USD | -89.58% |
| 2016 Q4 | -189 Thousand USD | -1990.0% |
| 2016 Q2 | 96 Thousand USD | -50.52% |
| 2015 Q1 | 35 Thousand USD | 105.88% |
| 2015 FY | 69 Thousand USD | 201.47% |
| 2015 Q2 | -104 Thousand USD | -397.14% |
| 2015 Q3 | -128 Thousand USD | -23.08% |
| 2015 Q4 | -1.22 Million USD | -853.13% |
| 2014 FY | -68 Thousand USD | -111.97% |
| 2014 Q2 | -59 Thousand USD | -15.69% |
| 2014 Q1 | -51 Thousand USD | -128.02% |
| 2014 Q3 | 24 Thousand USD | 140.68% |
| 2014 Q4 | 17 Thousand USD | -29.17% |
| 2013 FY | 568 Thousand USD | -82.75% |
| 2013 Q4 | 182 Thousand USD | 574.07% |
| 2013 Q3 | 27 Thousand USD | -87.67% |
| 2013 Q2 | 219 Thousand USD | 55.32% |
| 2013 Q1 | 141 Thousand USD | -86.24% |
| 2012 Q1 | 718 Thousand USD | -11.9% |
| 2012 Q4 | 1.02 Million USD | 50.51% |
| 2012 Q3 | 681 Thousand USD | -21.63% |
| 2012 Q2 | 869 Thousand USD | 21.03% |
| 2012 FY | 3.29 Million USD | -6.34% |
| 2011 Q4 | 815 Thousand USD | 150.06% |
| 2011 Q2 | 913 Thousand USD | 3281.48% |
| 2011 FY | 3.51 Million USD | 4.52% |
| 2011 Q3 | -1.62 Million USD | -278.31% |
| 2011 Q1 | 27 Thousand USD | -97.46% |
| 2010 Q3 | 676 Thousand USD | -16.02% |
| 2010 Q1 | 631 Thousand USD | 14.73% |
| 2010 FY | 3.36 Million USD | 117.03% |
| 2010 Q2 | 805 Thousand USD | 27.58% |
| 2010 Q4 | 1.06 Million USD | 57.1% |
| 2009 Q4 | 550 Thousand USD | -4.68% |
| 2009 FY | 1.55 Million USD | 17.69% |
| 2009 Q2 | -280 Thousand USD | 33.49% |
| 2009 Q3 | 577 Thousand USD | 306.07% |
| 2009 Q1 | -421 Thousand USD | -308.42% |
| 2008 Q2 | 449 Thousand USD | 416.2% |
| 2008 Q1 | -142 Thousand USD | 65.7% |
| 2008 FY | 1.31 Million USD | 33.71% |
| 2008 Q4 | 202 Thousand USD | -40.59% |
| 2008 Q3 | 340 Thousand USD | -24.28% |
| 2007 FY | 985 Thousand USD | 2997.06% |
| 2007 Q4 | -414 Thousand USD | -53.9% |
| 2007 Q3 | -269 Thousand USD | -185.67% |
| 2007 Q2 | 314 Thousand USD | 1182.76% |
| 2007 Q1 | -29 Thousand USD | -1550.0% |
| 2006 Q3 | 94 Thousand USD | 259.32% |
| 2006 Q4 | 2000.00 USD | -97.87% |
| 2006 Q2 | -59 Thousand USD | 16.9% |
| 2006 FY | -34 Thousand USD | 92.33% |
| 2006 Q1 | -71 Thousand USD | 61.83% |
| 2005 FY | -443 Thousand USD | -1130.56% |
| 2005 Q1 | -24 Thousand USD | -114.46% |
| 2005 Q2 | -49 Thousand USD | -104.17% |
| 2005 Q3 | -184 Thousand USD | -275.51% |
| 2005 Q4 | -186 Thousand USD | -1.09% |
| 2004 FY | -36 Thousand USD | -106.87% |
| 2004 Q1 | -161 Thousand USD | -267.71% |
| 2004 Q2 | 31 Thousand USD | 119.25% |
| 2004 Q3 | -72 Thousand USD | -332.26% |
| 2004 Q4 | 166 Thousand USD | 330.56% |
| 2003 Q1 | 489 Thousand USD | 51.39% |
| 2003 FY | 524 Thousand USD | -75.9% |
| 2003 Q4 | 96 Thousand USD | 1471.43% |
| 2003 Q3 | -7000.00 USD | 87.04% |
| 2003 Q2 | -54 Thousand USD | -111.04% |
| 2002 Q3 | 1.24 Million USD | 225.98% |
| 2002 FY | 2.17 Million USD | 451.78% |
| 2002 Q2 | 381 Thousand USD | 67.11% |
| 2002 Q1 | 228 Thousand USD | 1620.0% |
| 2002 Q4 | 323 Thousand USD | -73.99% |
| 2001 FY | 394 Thousand USD | -89.33% |
| 2001 Q3 | 160 Thousand USD | 24.03% |
| 2001 Q2 | 129 Thousand USD | -40.0% |
| 2001 Q1 | 215 Thousand USD | -90.97% |
| 2001 Q4 | -15 Thousand USD | -109.38% |
| 2000 Q1 | 636 Thousand USD | -9.14% |
| 2000 FY | 3.69 Million USD | 84.7% |
| 2000 Q4 | 2.38 Million USD | 1446.1% |
| 2000 Q3 | 154 Thousand USD | -70.55% |
| 2000 Q2 | 523 Thousand USD | -17.77% |
| 1999 Q1 | 100 Thousand USD | -50.0% |
| 1999 Q3 | 1 Million USD | 0.0% |
| 1999 FY | 2 Million USD | 900.0% |
| 1999 Q4 | 700 Thousand USD | -30.0% |
| 1999 Q2 | - USD | -100.0% |
| 1998 FY | 200 Thousand USD | -84.62% |
| 1998 Q4 | 200 Thousand USD | 100.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q1 | - USD | -100.0% |
| 1997 Q1 | 100 Thousand USD | -75.0% |
| 1997 FY | 1.3 Million USD | 62.5% |
| 1997 Q2 | 300 Thousand USD | 200.0% |
| 1997 Q3 | 200 Thousand USD | -33.33% |
| 1997 Q4 | 700 Thousand USD | 250.0% |
| 1996 FY | 800 Thousand USD | -32.2% |
| 1996 Q4 | 400 Thousand USD | 700.0% |
| 1996 Q3 | 50 Thousand USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1995 FY | 1.18 Million USD | 883.33% |
| 1994 FY | 120 Thousand USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | -Infinity% |
| BioElectronics Corporation | 466.38 Thousand USD | 92.281% |
| IR-Med Inc. | -17 Thousand USD | 311.765% |
| Polarean Imaging plc | 335.48 Thousand USD | 89.269% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 97.953% |
| Avitar, Inc. | 836.7 Thousand USD | 95.697% |
| AVITA Medical, Inc. | 41.68 Million USD | 99.914% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 3700.0% |
| Össur hf. | 485.57 Million USD | 99.993% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 118.431% |
| QHSLab, Inc. | 793.6 Thousand USD | 95.464% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | 99.993% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 99.785% |
| Escalon Medical Corp. | 5.14 Million USD | 99.3% |
| Aurora Spine Corporation | 8.21 Million USD | 99.562% |
| BrainsWay Ltd. | 23.09 Million USD | 99.844% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 105.1 Thousand USD | 65.748% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 99.897% |
| Vivos Inc. | -6036.00 USD | 696.421% |
| MicroPort Scientific Corporation | 532.09 Million USD | 99.993% |
| Kelyniam Global, Inc. | 2.03 Million USD | 98.232% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 104.757% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 36.389% |
| Nanomix Corporation | -69.45 Thousand USD | 151.83% |
| Theraclion SA | -1.08 Million USD | 103.332% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 93.873% |
| Positron Corporation | -353.46 Thousand USD | 110.185% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 96.557% |
| Lombard Medical, Inc. | 955 Thousand USD | 96.23% |
| ALR Technologies Inc. | 4945.00 USD | -628.008% |
| Stratec SE | 71.58 Million USD | 99.95% |
| Vycor Medical, Inc. | 1.31 Million USD | 97.264% |
| Heart Tronics, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 379.07% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 82.56% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 99.749% |
| VMS Rehab Systems, Inc. | -10.44 USD | 344927.586% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 86.596% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| United American Healthcare Corporation | -8000.00 USD | 550.0% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 96.709% |
| Urologix, Inc. | 6.09 Million USD | 99.409% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 111.368% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 94.954% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 99.999% |
| NIOX Group Plc | 28.13 Million USD | 99.872% |
| Fuse Medical, Inc. | 10.73 Million USD | 99.665% |
| Broncus Holding Corporation | 7.22 Million USD | 99.502% |
| Brain Scientific Inc. | 54.32 Thousand USD | 33.732% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 95.498% |
| Health Logic Interactive Inc. | - USD | -Infinity% |